Survival of mitomycin C-treated pancreatic islet xenografts is mediated by increased expression of transforming growth factor-β

Transplantation

Volumn 77, Issue 6, 2004, Pages 907-914

  Ise, Kazuya ^a   Kanazawa, Yukio ^a   Sato, Yoshihiro ^a   Matsuyama, Shinichi ^a   Gunji, Takashi ^a   Endo, Yuichi ^a   Hojo, Hiroshi ^a   Abe, Masafumi ^a   Gotoh, Mitsukazu ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN G; MESSENGER RNA; MITOMYCIN C; NEUTRALIZING ANTIBODY; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; T LYMPHOCYTE; XENOGRAFT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; GRAFT SURVIVAL; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MITOMYCIN; RATS; RATS, INBRED STRAINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS;

EID: 1842525035     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000116770.13517.0E     Document Type: Article

References (32)

1. Tanigawa T, Monden M, Gotoh M, et al. Pretreatment of recipients with mitomycin-C-treated spleen cells induces significant prolongation of cardiac allograft survival in rats. Transplant Proc 1994; 26: 3359.
2. Grochowiecki T, Gotoh M, Dono K, et al. Pretreatment of crude pancreatic islets with mitomycin C prolongs graft survival time in a xenogeneic rat-to-mouse model. Transplantation 1999; 67: 1474.
3. Grochowiecki T, Gotoh M, Dono K, et al. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ ICAM-1 pathway. Transplantation 2000; 69: 1567.
4. Sato Y, Grochowiecki T, Takeda Y, et al. Grafting of mitomycin C-treated islet xenograft under the kidney capsule produces a clear bleb. Cell Transplant 2000; 9: 693.
5. Liu ZG, Baskaren R, Lea-Chou E, et al. Three distinct signaling responses by murine fibroblasts to genotoxic stress. Nature 1996; 384: 273.
6. Canman C, Kasatan M. Three paths to stress relief. Nature 1996; 384: 213.
7. Fornace A, Amundson S, Bittner M, et al. The complexity of radiation stress responses: Analysis by informatics and functional genomics approaches. Gene Express 1999; 7: 387.
8. Han H-S, Jun H-S, Utsugi T, et al. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J Autoimmun 1996; 9: 331.
9. Zekzer D, Wong FS, Wen L, et al. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes 1997; 46: 1124.
10. Weiner HL. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18: 335.
11. King C, Davies J, Mueller R, et al. TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 1998; 8: 601.
12. Moritani M, Yoshimoto K, Wong SF, et al. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-β1. J Clin Invest 1998; 102: 499.
13. Piccirillo CA, Chang Y, Prud'homme GJ. TGF-β1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J Immunol 1998; 161: 3950.
14. Josien R, Douillard P, Guillot C, et al. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest 1998; 102: 1920.
15. Suarez-Pinzon W, Korbutt G, Power R, et al. Testicular Sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism. Diabetes 2000; 49: 1810.
16. Carel JC, Schreiber RD, Falqui L, et al. Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in monoclonal antibody to interferon gamma. Proc Natl Acad Sci USA 1990; 87: 1591.
17. Gotoh M, Maki T, Kiyoizumi T, et al. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40: 437.
18. Lau H, Reemtsma K, Hardy M. Prolongation of rat islet allograft survival by direct ultraviolet irradiation of the graft. Science 1984; 223: 607.
19. Gotoh M, Kanai T, Dono K, et al. Gamma-irradiation as a tool to reduce immunogenicity of islet allo- and xenografts. Horm Metab Res Suppl 1999; 2: 89.
20. Feng X, Zheng X, Yi S, et al. IL-10/Fc inhibits macrophage function and prolongs pancreatic islet xenograft survival. Transplantation 1999; 68: 1775.
21. Yi S, Feng X, Hawthorne W, et al. CD8+ T cells are capable of rejecting pancreatic islet xenografts. Transplantation 2000; 70: 896.
22. Wahl S, McCartney FN, Mergenhagen S. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today 1989; 10: 258.
23. Ahuja S, Paliogianni F, Yamada H, et al. Effect of transforming growth factor-beta on early and late activation events in human T cells. J Immunol 1993; 150: 3109.
24. Kehrl J, Taylor A, Delsing G, et al. Further studies of the role of transforming growth factor-beta in human B cell function. J Immunol 1989; 143: 1868.
25. Mule J, Schwarz S, Roberts A, et al. Transforming growth factor-beta inhibits the in vivo generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol Immunother 1988; 26: 95.
26. Tsunawaki S, Sporn M, Ding A, et al. Deactivation of macrophages by transforming growth factor-beta. Nature 1988; 334: 260.
27. Wallick S, Figari I, Morris R, et al. Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: Comparison of active and latent TGF-beta1. J Exp Med 1990; 172: 1777.
28. Raju G, Belland S, Eisen H. Prolongation of cardiac allograft survival with transforming growth factor-beta1 in rats. Transplantation 1994; 58: 392.
29. Qin L, Chavin K, Ding Y, et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Transplantation 1995; 59: 809.
30. Khanna AK, Cairns VR, Becker CG, et al. Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine. Transplantation 1999; 67: 882.
31. Gysemans C, Waer M, Valckx D, et al. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts. Diabetes 2000; 49: 1992.
32. Gohongi T, Fukumura D, Boucher Y, et al. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor beta1. Nat Med 1999; 5: 1203.